Impaired humoral response to vaccines among HIV-exposed uninfected infants

Clinical and Vaccine Immunology

Volumn 18, Issue 9, 2011, Pages 1406-1409

  Abramczuk, Beatriz Mariana ^a   Mazzola, Taís Nitsch ^a   Moreno, Yara Maria Franco ^a,c   Zorzeto, Tatiane Queiroz ^a   Quintilio, Wagner ^b   Wolf, Paulo Silva ^b   Blotta, Maria Heloisa ^a   Morcillo, André Moreno ^a   Da Silva, Marcos Tadeu Nolasco ^a   Vilela, Maria Marluce Dos Santos ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b INSTITUTO BUTANTAN   (Brazil)

^c FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B VACCINE; NEUTRALIZING ANTIBODY;

ANTIBODY DETECTION; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; DIPHTHERIA; FEMALE; GEOMETRY; HEPATITIS B; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOPHENOTYPING; INFANT; INFANT WELFARE; LYMPHOCYTE FUNCTION; MAJOR CLINICAL STUDY; MALE; PRENATAL EXPOSURE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; TETANUS; TETANUS PROPHYLAXIS; VIRAL CONTAMINATION; VIRUS IDENTIFICATION;

ANTIBODIES, BACTERIAL; BRAZIL; DIPHTHERIA; DIPHTHERIA-TETANUS-PERTUSSIS VACCINE; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B VACCINES; HIV INFECTIONS; HUMANS; IMMUNIZATION PROGRAMS; INFANT; INFANT, NEWBORN; MALE; TETANUS; TREATMENT OUTCOME;

EID: 80052505187     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.05065-11     Document Type: Article

References (38)

1. Abzug, M. J., et al. 2009. Immunogenicity and immunologic memory after hepatitis B virus booster vaccination in HIV-infected children receiving highly active antiretroviral therapy. J. Infect. Dis. 200:935-946.
2. Barret, B., et al. 2003. Persistent mitochondrial dysfunction in HIV-1-exposed but uninfected infants: Clinical screening in a large prospective cohort. AIDS. 17:1769-1785. (Pubitemid 37000095)
3. Borges-Almeida, E., et al. 2011. The impact of maternal HIV infection on cord blood lymphocyte subsets and cytokine profile in exposed non-infected newborns. BMC Infect. Dis. 11:38.
4. Bunders, M., C. Thorne, and M. L. Newell. 2005. Maternal and infant factors and lymphocyte, CD4 and CD8 cell counts in uninfected children of HIV-1-infected mothers. AIDS. 19:1071-1079. (Pubitemid 40961148)
5. Bunders, M. J., et al. 2005. Haematological parameters of HIV-1-uninfected infants born to HIV-1-infected mothers. Acta Paediatr. 94:1571-1577.
6. Carniel, E. F., et al. 2008. Immunogenicity and safety of combined intradermal recombinant Hepatitis B with BCG vaccines at birth. Vaccine 26:647-652.
7. Clemens, S. C., T. Azevedo, and A. Homma. 2003. Feasibility study of the immunogenicity and safety of a novel DTPw/Hib (PRP-T) Brazilian combination compared to a licensed vaccine in healthy children at 2, 4, and 6 months of age. Rev. Soc. Bras Med. Trop. 36:321-330. (Pubitemid 36869967)
8. Clerici, M., et al. 2000. T-lymphocyte maturation abnormalities in uninfected newborns and children with vertical exposure to HIV. Blood 96:3866-3871.
9. Faye, A., et al. 2007. Characterization of the main placental cytokine profiles from HIV-1-infected pregnant women treated with anti-retroviral drugs in France. Clin. Exp. Immunol. 149:430-439. (Pubitemid 47256145)
10. Feiterna-Sperling, C., et al. 2007. Hematologic effects of maternal antiretroviral therapy and transmission prophylaxis in HIV-1-exposed uninfected newborn infants. J. Acquir. Immune Defic. Syndr. 45:43-51. (Pubitemid 46684442)
11. Foca, M., et al. 2006. Gender differences in lymphocyte populations, plasma HIV RNA levels, and disease progression in a cohort of children born to women infected with HIV. Pediatrics. 118:146-155. (Pubitemid 46071157)
12. Gesner, M., et al. 1994. Alteration in the proportion of CD4 T lymphocytes in a subgroup of human immunodeficiency virus-exposed-uninfected children. Pediatrics. 93:624-630. (Pubitemid 24106610)
13. Hendriksen, C. F., J. W. Van der Gun, and J. G. Kreeftenberg. 1989. Combined estimation of tetanus and diphtheria antitoxin in human sera by the in vitro toxin-binding inhibition (ToBI) test. J. Biol. Stand. 17:191-200. (Pubitemid 19110166)
14. Hygino, J., et al. 2008. Altered immunological reactivity in HIV-1-exposed uninfected neonates. Clin. Immunol. 127:340-347.
15. Jones, C. E., et al. 2011. Maternal HIV infection and antibody responses against vaccine-preventable diseases in uninfected infants. JAMA 305:576-584.
16. Lao-Araya, M., T. Puthanakit, L. Aurpibul, T. Sirisanthana, and V. Sirisanthana. 2007. Antibody response to hepatitis B re-vaccination in HIV-infected children with immune recovery on highly active antiretroviral therapy. Vaccine 25:5324-5329. (Pubitemid 46977535)
17. Le Chenadec, J., M. J. Mayaux, C. Guihenneuc-Joyaux, and S. Blanche. 2003. Perinatal antiretroviral treatment and hematopoiesis in HIV-unifected infants. AIDS 17:2053-2061. (Pubitemid 37297153)
18. Madhi, S. A., et al. 2005. Immunogenicity and effectiveness of Haemophilus influenzae type b conjugate vaccine in HIV infected and uninfected African children. Vaccine 23:5517-5525. (Pubitemid 41608600)
19. Marcovistz, R., D. C. Matos, R. A. Georgini, and D. Sakauchi. 2002. Potency control of diphtheria component in adsorbed vaccines by in vitro neutralization tests. Biologicals 30:105-112. (Pubitemid 36284689)
20. Miyamoto, M., et al. 2010. Low CD4+ T-cell levels and B-cell apoptosis in vertically HIV-exposed noninfected children and adolescents. J. Trop. Pediatr. 56:427-432.
21. Mofenson, L. M., et al. 2009. Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: Recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics. MMWR Recomm. Rep. 58:1-166.
22. Moss, W. J., C. J. Clements, and N. A. Halsey. 2003. Immunization of children at risk of infection with human immunodeficiency virus. Bulletin of the World Health Organization. 81:61-70. (Pubitemid 36168655)
23. National Center for Immunization and Respiratory Diseases. 2011. General recommendations on immunization-recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm. Rep. 60:1-64.
24. Nielsen, S. D., et al. 2001. Impaired progenitor cell function in HIV-negative infants of HIV-positive mothers results in decreased thymic output and low CD4 counts. Blood 98:398-404.
25. Ono, E., et al. 2008. Imbalance of naive and memory T lymphocytes with sustained high cellular activation during the first year of life from uninfected children born to HIV-1-infected mothers on HAART. Braz. J. Med. Biol. Res. 41:700-708.
26. Pippi, F., et al. 2008. Serological response to hepatitis B virus vaccine in HIV-infected children in Tanzania. HIV Med. 9:519-525.
27. Romano, M. F., et al. 2006. Increased CD154 expression in uninfected infants born to HIV-positive mothers exposed to antiretroviral prophylaxis. Viral Immunol. 19:363-372. (Pubitemid 44735050)
28. Rutstein, R. M., B. Rudy, C. Codispoti, and B. Watson. 1994. Response to hepatitis B immunization by infants exposed to HIV. AIDS 8:1281-1284. (Pubitemid 24267751)
29. Scott, S., et al. 2007. The influence of HIV-1 exposure and infection on levels of passively acquired antibodies to measles virus in Zambian infants. Clin. Infect. Dis. 45:1417-1424. (Pubitemid 351411869)
30. Siriaksorn, S., T. Puthanakit, T. Sirisanthana, and V. Sirisanthana. 2006. Prevalence of protective antibody against hepatitis B virus in HIV-infected children with immune recovery after highly active antiretroviral therapy. Vaccine 24:3095-3099.
31. Sonobe, M. H., et al. 2007. Determination of low tetanus or diphtheria antitoxin titers in sera by a toxin neutralization assay and a modified toxin-binding inhibition test. Braz. J. Med. Biol. Res. 40:69-76. (Pubitemid 46117720)
32. Souza Matos, D. C. S., et al. 2002. Immunogenicity test of tetanus component in adsorbed vaccines by toxin binding inhibition test. Mem. Inst. Oswaldo Cruz 97:909-913.
33. Tejiokem, M. C., et al. 2007. HIV-infected children living in Central Africa have low persistence of antibodies to vaccines used in the Expanded Program on Immunization. PLoS One 2:e1260.
34. Tejiokem, M. C., et al. 2009. Whole-cell pertussis vaccine induces low antibody levels in human immunodeficiency virus-infected children living in sub-Saharan Africa. Clin. Vaccine Immunol. 16:479-483.
35. Thaithumyanon, P., S. Punnahitananda, P. Praisuwanna, U. Thisyakorn, and K. Ruxrungtham. 2002. Antibody response to hepatitis B immunization in infants born to HIV-infected mothers. J. Med. Assoc. Thai. 85:277-282. (Pubitemid 34875593)
36. Velilla, P. A., et al. 2008. Effect of intrauterine HIV-1 exposure on the frequency and function of uninfected newborns' dendritic cells. Clin. Immunol. 126:243-250.
37. World Health Organization. 2010. Hepatitis B vaccines: WHO position paper-recommendations. Vaccine 28:589-590.
38. Zorzeto, T. Q., et al. 2009. Immunogenicity of a whole-cell pertussis vaccine with low lipopolysaccharide content in infants. Clin. Vaccine Immunol. 16:544-550.